Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia

Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia

Background: Paliperidone palmitate 3-monthly (PP3M) formulation is a long-acting, injectable antipsychotic treatment approved in many countries worldwide for the maintenance treatment of adult patients with schizophrenia. This single-arm, open-label, phase IIIb study evaluated the efficacy and safet...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Paz Garcia-Portilla (Author), Pierre-Michel Llorca (Author), Giuseppe Maina (Author), Vasilis P. Bozikas (Author), Halise Devrimci-Ozguven (Author), Sung-Wan Kim (Author), Paul Bergmans (Author), Irina Usankova (Author), Katalin Pungor (Author)
Format: Book
Published: SAGE Publishing, 2020-05-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items